CVR: 38215663
DKK 16,777,505
Gross profit
Net result: DKK -962,688
Kim Raabymagle, Lena Birgitta Andersson Hofsberger
1 more
CVR · view ownership and management
Director role ended: Fredrik Anjou
CVR · 27/03/2025
View the full event history
PharmaRelations ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Åsa Uppströmer. The company is owned by Kim Raabymagle, Lena Birgitta Andersson Hofsberger and PharmaRelations AB. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 16,777,505 and a net result of DKK -962,688 compared with DKK 253,685 the year before. Equity in the 2025 report amounted to DKK 5,612,668.
Source: annual report 2025, Danish Business Authority
PharmaRelations ApS has demonstrated a fluctuating financial trajectory, with gross profit peaking at 23.6 million DKK in 2022 before declining to 16.8 million DKK in 2025. Profitability has also varied significantly, transitioning from a profit of 2.6 million DKK in 2021 to a loss of nearly 1 million DKK in 2025, indicating potential operational challenges. Despite these fluctuations, the company's equity remains relatively stable, ending at 5.6 million DKK in 2025, which suggests a solid capital base. The absence of disclosed revenue figures limits a comprehensive assessment, but the overall trend points to a need for strategic adjustments to enhance profitability and stabilize growth within the competitive labor market industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive konulentvirksomhed (Talent Services) inden for Life Science samt hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -963 t. | 9.5 mio. | 5.6 mio. | 22 | |
| 202401/01/2024 – 31/12/2024 | - | 254 t. | 11.8 mio. | 6.6 mio. | 27 | |
| 202301/01/2023 – 31/12/2023 | - | 699 t. | 10 mio. | 6.3 mio. | 28 | |
| 202201/01/2022 – 31/12/2022 | - | 675 t. | 8.6 mio. | 5.6 mio. | 29 | |
| 202101/01/2021 – 31/12/2021 | - | 2.6 mio. | 9.1 mio. | 4.9 mio. | 20 | |
| 202001/01/2020 – 31/12/2020 | - | 1.5 mio. | 8.3 mio. | 2.4 mio. | 17 | |
| 201901/01/2019 – 31/12/2019 | 11.8 mio. | 430 t. | 5 mio. | 900 t. | 10 | |
| 201801/01/2018 – 31/12/2018 | - | 488 t. | 3.6 mio. | 470 t. | - |
Compared to 1.149 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationPharmaRelations ApS was founded on 22 November 2016.
PharmaRelations ApS is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (industry code 749990).
PharmaRelations ApS had 6 employees in 2018 according to the Danish CVR register.
PharmaRelations ApS is owned by Kim Raabymagle, Lena Birgitta Andersson Hofsberger and PharmaRelations AB.
pharmarelations.dk belongs to PharmaRelations ApS, CVR number 38215663.
In 2025, PharmaRelations ApS reported a gross profit of DKK 16,777,505.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new email: [email protected], new website: www.pharmarelations.dk (August 24, 2026).
PharmaRelations ApS has published its annual report for 2025. Gross profit came to DKK 16,777,505, and the net result was DKK -962,688.
PharmaRelations ApS has published its annual report for 2024. Gross profit came to DKK 22,361,029, and the net result was DKK 253,685.
As of March 27, 2025, Åsa Uppströmer is registered as director of PharmaRelations ApS.
As of March 27, 2025, Fredrik Anjou has stepped down as adm. dir. of PharmaRelations ApS.
PharmaRelations ApS has published its annual report for 2023. Gross profit came to DKK 23,251,520, and the net result was DKK 699,388.
As of April 4, 2024, TREKRONER REVISION A/S - GODKENDTE REVISORER has been appointed auditor of PharmaRelations ApS.
PharmaRelations ApS has published its annual report for 2022. Gross profit came to DKK 23,599,548, and the net result was DKK 674,589.
PharmaRelations ApS has published its annual report for 2021. Gross profit came to DKK 20,105,088, and the net result was DKK 2,553,548.
PharmaRelations ApS has published its annual report for 2020. Gross profit came to DKK 14,605,538, and the net result was DKK 1,493,884.
PharmaRelations ApS has published its annual report for 2019. Revenue came to DKK 11,821,163, and the net result was DKK 429,853.
PharmaRelations ApS has published its annual report for 2018. Gross profit came to DKK 5,138,110, and the net result was DKK 488,382.
As of November 30, 2018, Lena Birgitta Andersson Hofsberger has left the board of directors of PharmaRelations ApS.
As of November 30, 2018, Fredrik Gunnar Åke Anjou has left the board of directors of PharmaRelations ApS.
As of November 30, 2018, Lena Birgitta Andersson Hofsberger has left the board of directors of PharmaRelations ApS.
As of November 30, 2018, Fredrik Gunnar Åke Anjou has stepped down as director of PharmaRelations ApS.
PharmaRelations ApS has published its interim report for the period November 22, 2016 – December 31, 2017.
As of December 28, 2017, Kim Raabymagle is registered as an owner of PharmaRelations ApS with an ownership share of 5%.
As of November 22, 2016, Lena Birgitta Andersson Hofsberger has joined the board of directors of PharmaRelations ApS.
As of November 22, 2016, Fredrik Gunnar Åke Anjou has joined the board of directors of PharmaRelations ApS.
As of November 22, 2016, Lena Birgitta Andersson Hofsberger has joined the board of directors of PharmaRelations ApS.
As of November 22, 2016, Fredrik Gunnar Åke Anjou is registered as director of PharmaRelations ApS.
As of November 22, 2016, Fredrik Anjou is registered as adm. dir. of PharmaRelations ApS.
As of November 22, 2016, is registered as an owner of PharmaRelations ApS with an ownership share of 90%.
As of November 22, 2016, is registered as an owner of PharmaRelations ApS with an ownership share of 90%.
PharmaRelations ApS was founded on November 22, 2016.
Companies in the same industry and area
CVR 42704970
CVR 33155530
CVR 43789759
CVR 44775964
CVR 32337740
